Olink Holding AB (publ) (NASDAQ:OLK) Rating Increased to Buy at Zacks Investment Research

Olink Holding AB (publ) (NASDAQ:OLKGet Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Zacks.com reports. The firm currently has a $13.00 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 20.48% from the company’s current price.

According to Zacks, “Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden. “

OLK has been the subject of several other research reports. BTIG Research cut their price objective on Olink Holding AB (publ) from $44.00 to $37.00 in a report on Wednesday, February 16th. The Goldman Sachs Group reduced their target price on Olink Holding AB (publ) from $34.00 to $20.00 and set a “neutral” rating for the company in a report on Wednesday, April 13th. Finally, Morgan Stanley reduced their target price on Olink Holding AB (publ) from $33.00 to $32.00 and set an “equal weight” rating for the company in a report on Monday, February 14th.

Shares of Olink Holding AB (publ) stock opened at $10.79 on Thursday. The company has a quick ratio of 5.15, a current ratio of 6.23 and a debt-to-equity ratio of 0.01. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -34.81 and a beta of 1.94. The business has a fifty day simple moving average of $15.27 and a 200-day simple moving average of $17.96. Olink Holding AB has a fifty-two week low of $9.21 and a fifty-two week high of $38.78.

Olink Holding AB (publ) (NASDAQ:OLKGet Rating) last announced its quarterly earnings data on Thursday, May 12th. The company reported ($0.10) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.06. Olink Holding AB (publ) had a negative return on equity of 7.46% and a negative net margin of 34.81%. During the same period last year, the business earned ($0.48) earnings per share. Analysts anticipate that Olink Holding AB will post -0.41 earnings per share for the current fiscal year.

A number of large investors have recently bought and sold shares of OLK. UBS Group AG raised its position in Olink Holding AB (publ) by 174.3% during the first quarter. UBS Group AG now owns 7,071 shares of the company’s stock valued at $125,000 after buying an additional 4,493 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in Olink Holding AB (publ) during the fourth quarter valued at $178,000. Raymond James & Associates acquired a new position in Olink Holding AB (publ) during the first quarter valued at $209,000. Jump Financial LLC acquired a new position in Olink Holding AB (publ) during the third quarter valued at $226,000. Finally, Marshall Wace LLP acquired a new position in Olink Holding AB (publ) during the third quarter valued at $287,000. 28.36% of the stock is currently owned by hedge funds and other institutional investors.

About Olink Holding AB (publ) (Get Rating)

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.

Featured Stories

Get a free copy of the Zacks research report on Olink Holding AB (publ) (OLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.